Date: August 10–13, 2026
Location: Omni Boston Hotel at the Seaport, Boston, MA
High Q Technologies is excited to exhibit at Bioprocessing Summit 2026, one of the leading events for scientists and professionals working in biologics development, analytical characterization, and bioprocess innovation. If you're attending the Bioprocessing Summit, visit us to learn how Electron Paramagnetic Resonance (EPR) spectroscopy is helping researchers gain a more complete understanding of protein dynamics.
Booth #401
Proteins are dynamic molecules, thus at Bioprocessing Summit 2026, we'll be demonstrating how High Q Technologies' EPR spectrometers help researchers close the conformation gap by measuring protein dynamics, conformational changes, and molecular interactions that are difficult to capture with conventional methods.
If you're developing therapeutic proteins, improving protein characterization, or looking for complementary analytical techniques, we'd love to discuss how EPR can support your research and development goals.
If you're attending Bioprocessing Summit 2026, stop by Booth #401 or schedule a meeting below with our team. We look forward to seeing you in Boston.
A protein conformational change is often described as a transition from one structural state to another: open to closed, inactive to active, or apo to ligand-bound. That language is useful for describing structural differences, but it can obscure the physical problem that determines how a protein behaves in solution.
Artificial intelligence has changed the starting point for structural biology. Protein structure prediction tools such as AlphaFold can generate highly accurate structural models for many proteins, including proteins for which experimentally determined structures are unavailable.
Structure-based drug design uses the three-dimensional structure of a target protein to identify functional binding sites and design drug molecules that complement their shape, size, and electrostatic properties. This approach has enabled major advances in medicine, including HIV protease inhibitors, antibiotics, and targeted cancer therapies such as imatinib.
Ready to see FATHOM in action?
Our applications specialists will walk you through a demo, answer technical questions, and help you assess fit for your specific research program.